Professional
Added to YB: 2024-05-29
Pitch date: 2024-03-31
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+28.43%
current return
Author Info
No bio for this author
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 28.5B
Pitch Price
EUR 28.37
Price Target
N/A
Dividend
0.38%
EV/EBITDA
7.40
P/E
-144.19
EV/Sales
1.33
Sector
Pharmaceuticals
Category
turnaround
Harris Associates Global Strategy Portfolio Holding: Bayer Aktiengesellschaft
BAYN.DE: Recent RoundUp jury verdict bigger than avg but likely reduced on appeal; since won 2 cases. Capital markets day lacked major updates as litigation strategy kept private, no mid-term targets, and break-up deferred for balance sheet. Support mgmt's profitability & cash focus + bureaucracy cuts. 2023 results & 2024 guide in line.
Read full article (1 min)